78 related articles for article (PubMed ID: 32988877)
1. Mxi-2 Dependent Regulation of p53 in Prostate Cancer.
KÖditz B; Fries JWU; GÖbel H; Paffenholz P; Richter K; Heidenreich A; VON Brandenstein M
Anticancer Res; 2020 Oct; 40(10):5539-5544. PubMed ID: 32988877
[TBL] [Abstract][Full Text] [Related]
2. MiR-150 promotes the cell invasion of prostate cancer cells by directly regulating the expression of p53.
Zhao Y; Zhu Y; Song J
Pharmazie; 2016 Sep; 71(9):533-536. PubMed ID: 29441850
[TBL] [Abstract][Full Text] [Related]
3. Vimentin 3 Expression in Prostate Cancer Cells.
KÖditz B; Stog A; GÖbel H; Heidegger I; Fries J; Heidenreich A; VON Brandenstein M
Anticancer Res; 2021 Jan; 41(1):169-174. PubMed ID: 33419810
[TBL] [Abstract][Full Text] [Related]
4. Neuropathic pain induced by spinal cord injury: Role of endothelin ETA and ETB receptors.
Forner S; Martini AC; Andrade EL; Rae GA
Neurosci Lett; 2016 Mar; 617():14-21. PubMed ID: 26861196
[TBL] [Abstract][Full Text] [Related]
5. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
7. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
[TBL] [Abstract][Full Text] [Related]
9. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
10. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
11. TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6.
Knobloch J; Yanik SD; Körber S; Stoelben E; Jungck D; Koch A
Biochem Pharmacol; 2016 Sep; 116():188-99. PubMed ID: 27422754
[TBL] [Abstract][Full Text] [Related]
12. [Epidermal growth factor up-regulates the mRNA expression of endothelin-1 and its receptors in prostate cancer PC-3 cell lines].
Jia RP; Jiang YF; Xu LW; Wang SK; Wang ZZ; Li WC; He BS
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):15-9. PubMed ID: 18297804
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
Zhang X; Jin K; Luo JD; Liu B; Xie LP
Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
[TBL] [Abstract][Full Text] [Related]
14. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
16. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
17. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma.
Boll K; Reiche K; Kasack K; Mörbt N; Kretzschmar AK; Tomm JM; Verhaegh G; Schalken J; von Bergen M; Horn F; Hackermüller J
Oncogene; 2013 Jan; 32(3):277-85. PubMed ID: 22391564
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 downregulates Mas receptor expression in human cardiomyocytes.
Chen Z; Tang Y; Yang Z; Liu S; Liu Y; Li Y; He W
Mol Med Rep; 2013 Sep; 8(3):871-6. PubMed ID: 23836146
[TBL] [Abstract][Full Text] [Related]
19. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
